DK413987D0 - Farmaceutiske praeparater - Google Patents

Farmaceutiske praeparater

Info

Publication number
DK413987D0
DK413987D0 DK413987A DK413987A DK413987D0 DK 413987 D0 DK413987 D0 DK 413987D0 DK 413987 A DK413987 A DK 413987A DK 413987 A DK413987 A DK 413987A DK 413987 D0 DK413987 D0 DK 413987D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
DK413987A
Other languages
English (en)
Other versions
DK169404B1 (da
DK413987A (da
Inventor
Peter Thaddeus Gallagher
Terence Alan Hicks
Graham Walter Mullier
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DK413987D0 publication Critical patent/DK413987D0/da
Publication of DK413987A publication Critical patent/DK413987A/da
Application granted granted Critical
Publication of DK169404B1 publication Critical patent/DK169404B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • C07D261/16Benzene-sulfonamido isoxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK413987A 1986-08-08 1987-08-07 Substitueret phenylamidforbindelse, fremgangsmåde til fremstilling deraf, anvendelse deraf til brug som farmaceutisk middel og farmaceutisk præparat indeholdende forbindelsen DK169404B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868619432A GB8619432D0 (en) 1986-08-08 1986-08-08 Pharmaceutical compounds
GB8619432 1986-08-08

Publications (3)

Publication Number Publication Date
DK413987D0 true DK413987D0 (da) 1987-08-07
DK413987A DK413987A (da) 1988-02-09
DK169404B1 DK169404B1 (da) 1994-10-24

Family

ID=10602473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK413987A DK169404B1 (da) 1986-08-08 1987-08-07 Substitueret phenylamidforbindelse, fremgangsmåde til fremstilling deraf, anvendelse deraf til brug som farmaceutisk middel og farmaceutisk præparat indeholdende forbindelsen

Country Status (23)

Country Link
US (1) US4892963A (da)
EP (1) EP0257882B1 (da)
JP (1) JPS63239259A (da)
KR (2) KR880002815A (da)
CN (1) CN1015256B (da)
AR (2) AR244660A1 (da)
AT (1) ATE65494T1 (da)
AU (1) AU604737B2 (da)
CA (1) CA1317964C (da)
DE (1) DE3771611D1 (da)
DK (1) DK169404B1 (da)
EG (1) EG18269A (da)
ES (1) ES2031510T3 (da)
GB (1) GB8619432D0 (da)
GR (1) GR3002714T3 (da)
HU (1) HU197559B (da)
IL (1) IL83432A (da)
MX (1) MX174371B (da)
NZ (1) NZ221352A (da)
PH (1) PH22821A (da)
PT (1) PT85476B (da)
RU (1) RU1771472C (da)
ZA (1) ZA875813B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US4975462A (en) * 1988-07-29 1990-12-04 Bristol-Myers Company Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
DE59010701D1 (de) * 1990-05-18 1997-05-22 Hoechst Ag Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf 3-Cycloalkyl-prop-2- enamide derivatives
ES2079765T3 (es) * 1991-10-23 1996-01-16 Hoechst Ag Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
TW314467B (da) * 1993-03-31 1997-09-01 Hoechst Ag
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
US5814649A (en) * 1994-10-17 1998-09-29 Hoechst Pharmaceuticals & Chemicals K.K. Preventive and remedy for type 1 allergic diseases
DE19702988A1 (de) * 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
HUP0204069A3 (en) * 1999-12-16 2005-01-28 Teva Pharma Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
YU61602A (sh) 2000-02-15 2006-01-16 Teva Pharmaceutical Industries Ltd. Postupak za dobijanje leflunomida
US6894184B2 (en) 2003-03-18 2005-05-17 Aventis Pharma Deutschland Gmbh Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides
DE10311763A1 (de) * 2003-03-18 2004-10-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden
WO2015077535A2 (en) 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK545976A (da) * 1975-12-11 1977-06-12 Hoechst Ag Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten
DE2655009A1 (de) * 1976-12-04 1978-06-15 Hoechst Ag Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
IL60269A (en) * 1979-06-11 1983-12-30 Ciba Geigy Alpha-carbamoyl-pyrrolpropionitriles,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
RU1771472C (ru) 1992-10-23
AR247876A1 (es) 1995-04-28
GB8619432D0 (en) 1986-09-17
HU197559B (en) 1989-04-28
EP0257882A1 (en) 1988-03-02
ZA875813B (en) 1989-04-26
AU604737B2 (en) 1991-01-03
AU7668187A (en) 1988-02-11
HUT44523A (en) 1988-03-28
AR244660A1 (es) 1993-11-30
IL83432A (en) 1992-06-21
NZ221352A (en) 1989-10-27
JPS63239259A (ja) 1988-10-05
KR880002815A (ko) 1988-05-11
IL83432A0 (en) 1988-01-31
EP0257882B1 (en) 1991-07-24
DE3771611D1 (de) 1991-08-29
EG18269A (en) 1992-12-30
ES2031510T3 (es) 1992-12-16
MX7668A (es) 1993-08-01
PT85476B (pt) 1990-06-29
US4892963A (en) 1990-01-09
KR880002823A (ko) 1988-05-11
ATE65494T1 (de) 1991-08-15
PT85476A (en) 1987-09-01
CN1015256B (zh) 1992-01-01
GR3002714T3 (en) 1993-01-25
CA1317964C (en) 1993-05-18
PH22821A (en) 1989-01-19
MX174371B (es) 1994-05-11
DK169404B1 (da) 1994-10-24
DK413987A (da) 1988-02-09
CN87105516A (zh) 1988-02-24

Similar Documents

Publication Publication Date Title
NO922005D0 (no) Farmasoeytiske preparater
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK546886D0 (da) Farmaceutisk praeparat
DK89090A (da) Farmaceutisk praeparat
DK413987D0 (da) Farmaceutiske praeparater
DK149988A (da) Stabile farmaceutiske praeparater
DK705488D0 (da) Farmaceutisk praeparat
DK184087A (da) Farmaceutiske praeparater med forbedret biotilgaengelighed
DK259186A (da) Nasale farmaceutiske praeparater
FI913100A7 (fi) Farmaseuttiset valmisteet
DK652787D0 (da) Farmaceutiske praeparater
DK288686D0 (da) Farmaceutiske praeparater
NO874193D0 (no) Farmasoeytiske preparater.
MX5577A (es) Formulacion farmaceutica
DK52086A (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DK401387D0 (da) Benzopyranderivatholdige praeparater
DK447887A (da) Frysetoerrede farmaceutiske praeparater
DK142487D0 (da) Farmaceutiske midler
DK139388D0 (da) Farmaceutisk praeparat
DK276288D0 (da) Farmaceutisk praeparat
DK503386D0 (da) Peptidpraeparater
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater
DK138888A (da) Farmaceutisk praeparat
DK428287D0 (da) Nasalt farmaceutisk praeparat
SE8504793D0 (sv) Pharmaceutical preparations

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed